In considering where an invention was ‘completed’ the CNIPA’s invalidation raises issues for any company carrying out R&D in China, says Jennifer Che of Eagle IP. China and the US are similar in that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback